Full Year 2018 Verona Pharma PLC Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Verona Pharma Full Year 2018 Earnings Conference Call. (Operator Instructions) I would now like to turn the conference over to your host, Ms. Stephanie Carrington with Investor Relations. Ma'am, you may begin.
Thank you, operator. Good morning or afternoon depending on where you are, and welcome to today's call to review Verona Pharma's results for the 12 months ended December 31, 2018.
On this call, I am joined today by Jan-Anders Karlsson, Chief Executive Officer; and Piers Morgan Chief Financial Officer. I trust that you have seen the press release that was issued this morning before market open. It includes the results for the 12 months ended December 31, 2018, as well as the operational update. If you have not, the press release is also available on the Investor Relations portion of Verona Pharma's website.
On today's call, Jan-Anders will first provide a clinical development and business update for the full year ended 2018 as well as the quarter
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
